Resolor Use In Pregnancy & Lactation

Pregnancy: Experience with Prucalopride succinate (Resolor during pregnancy is limited. Cases of spontaneous abortion have been observed during clinical studies, although, in the presence of other risk factors, the relationship to Prucalopride succinate (Resolor) is unknown. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition or postnatal development (see Pharmacology: Toxicology: Non-Clinical Information under Actions). Prucalopride succinate (Resolor) is not recommended during pregnancy. Women of childbearing potential should use effective contraception during treatment with Prucalopride succinate (Resolor).
Nursing Mothers: Prucalopride is excreted in breast milk. However, at therapeutic doses of Prucalopride succinate (Resolor) no effects on the breastfed newborns/infants are anticipated. In the absence of human data in women who breastfed while taking Prucalopride succinate (Resolor), it is not recommended to use Prucalopride succinate (Resolor) during breast-feeding.
Fertility: Animal studies indicate that there is no effect on male or female fertility.